Avantax Planning Partners, Inc. Insulet Corp Transaction History

Avantax Planning Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$73.27 - $105.19 $6,814 - $9,782	-93 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$81.43 - $108.13 $7,572 - $10,056	93 New	93 $10,000
Q2 2018 Aug 13, 2018	SELL	$83.27 - $101.93 $10,158 - $12,435	-122 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$68.49 - $87.2 $8,355 - $10,638	122 New	122 $10,000

752

63.2M

467K

639K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.